Patient-Reported Outcomes (PROs) From the Phase 3 A.R.R.O.W. Study Comparing Once-Weekly versus Twice-Weekly Carfilzomib Dosing in Relapsed and Refractory Multiple Myeloma (RRMM)

Phase 3 ◽

12 / Patient-Reported Outcomes (PROs) From the Phase 3 A.R.R.O.W. Study Comparing Once-Weekly Versus Twice-Weekly Carfilzomib Dosing in Relapsed and Refractory Multiple Myeloma (RRMM)

10.26226/morressier.5b3b802db1b87b000eceda38 ◽

2018 ◽

Author(s):

Moreau Philippe

Keyword(s):

Multiple Myeloma ◽

Phase 3 ◽

Patient-reported outcomes in relapsed/refractory multiple myeloma: a systematic review

Supportive Care in Cancer ◽

10.1007/s00520-018-4137-x ◽

2018 ◽

Vol 26 (7) ◽

pp. 2075-2090 ◽

Cited By ~ 13

Author(s):

Francesco Sparano ◽

Michele Cavo ◽

Pasquale Niscola ◽

Tommaso Caravita ◽

Fabio Efficace

Keyword(s):

Systematic Review ◽

Multiple Myeloma ◽

Patient reported outcomes (PROs) of multiple myeloma (MM) patients treated with panobinostat (PAN) after ≥2 lines of therapy based on the international phase 3, randomized, double-blind, placebo-controlled, PANORAMA-1 trial.

Journal of Clinical Oncology ◽

10.1200/jco.2016.34.15_suppl.8054 ◽

2016 ◽

Vol 34 (15_suppl) ◽

pp. 8054-8054

Author(s):

Paul G. Richardson ◽

Sagar Lonial ◽

Robert L. Schlossman ◽

Anuja Nidumolu Roy ◽

Istvan Majer ◽

...

Keyword(s):

Multiple Myeloma ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Patient-reported outcomes of multiple myeloma patients treated with panobinostat after ≥2 lines of therapy based on the international phase 3, randomized, double-blind, placebo-controlled PANORAMA-1 trial

British Journal of Haematology ◽

10.1111/bjh.15248 ◽

2018 ◽

Vol 181 (5) ◽

pp. 628-636 ◽

Cited By ~ 4

Author(s):

Paul G. Richardson ◽

Robert L. Schlossman ◽

Anuja N. Roy ◽

Ashok Panneerselvam ◽

Suddhasatta Acharyya ◽

...

Keyword(s):

Multiple Myeloma ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

How are patient-reported outcomes and symptoms being measured in adults with relapsed/refractory multiple myeloma? A systematic review

Quality of Life Research ◽

10.1007/s11136-019-02392-6 ◽

2019 ◽

Vol 29 (6) ◽

pp. 1419-1431

Author(s):

Matthew R. LeBlanc ◽

Rachel Hirschey ◽

Ashley Leak Bryant ◽

Thomas W. LeBlanc ◽

Sophia K. Smith

Keyword(s):

Systematic Review ◽

Multiple Myeloma ◽

Assessing the Effect of Pomalidomide or Carfilzomib Treatment on Patient-Reported Outcomes Among Patients With Relapsed/Refractory Multiple Myeloma

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/j.clml.2019.09.443 ◽

2019 ◽

Vol 19 (10) ◽

pp. e268-e269

Author(s):

Shaloo Gupta ◽

Zoe Clancy ◽

Ronda Copher ◽

Aaron Seth Rosenberg

Keyword(s):

Multiple Myeloma ◽

Patient-Reported Outcomes In Relapsed/Refractory Multiple Myeloma (Rrmm) In The Overall And Japanese Populations From Eloquent-2

Value in Health ◽

10.1016/j.jval.2016.08.254 ◽

2016 ◽

Vol 19 (7) ◽

pp. A891-A892

Author(s):

J McKendrick ◽

T Zyczynski ◽

A Kudlac ◽

C Davis ◽

D Cella

Keyword(s):

Multiple Myeloma ◽

Patient‐reported outcomes in relapsed/refractory multiple myeloma treated with melflufen plus dexamethasone: analyses from the Phase II HORIZON study

British Journal of Haematology ◽

10.1111/bjh.17887 ◽

2021 ◽

Author(s):

Alessandra Larocca ◽

Xavier Leleu ◽

Cyrille Touzeau ◽

Joan Bladé ◽

Agne Paner ◽

...

Keyword(s):

Multiple Myeloma ◽

Phase Ii ◽

Patient-Reported Outcomes from Two Randomized, Double-Blind, Vehicle-Controlled Phase 3 Trials in Axillary Hyperhidrosis (ATMOS-1 & ATMOS-2)

SKIN The Journal of Cutaneous Medicine ◽

10.25251/skin.1.supp.95 ◽

2017 ◽

Vol 1 ◽

pp. s96

Author(s):

David M Pariser ◽

Adelaide A Hebert ◽

Janice Drew ◽

John Quiring ◽

Dee Anna Glaser

Keyword(s):

Axillary Hyperhidrosis ◽

Phase 3 ◽

Double Blind ◽

Abstract Not AvailableDisclosure: Study supported by Dermira.

Patient-Reported Outcomes from Two Randomized, Double-Blind, Vehicle Controlled Phase 3 Trials in Axillary Hyperhidrosis (ATMOS-1 & ATMOS-2)

SKIN The Journal of Cutaneous Medicine ◽

10.25251/skin.2.supp.41 ◽

2018 ◽

Vol 2 ◽

pp. S41

Author(s):

David M Pariser ◽

Adelaide A Hebert ◽

Janice Drew ◽

John Quiring ◽

Dee Anna Glaser

Keyword(s):

Axillary Hyperhidrosis ◽

Phase 3 ◽

Double Blind ◽

Abstract not available. Disclosures: Study supported by Dermira. Copyright SKIN 2018